Metformin as an Adjuvant to Photodynamic Therapy in Resistant Basal Cell Carcinoma Cells

Photodynamic Therapy (PDT) with methyl-aminolevulinate (MAL-PDT) is being used for the treatment of Basal Cell Carcinoma (BCC), although resistant cells may appear. Normal differentiated cells depend primarily on mitochondrial oxidative phosphorylation (OXPHOS) to generate energy, but cancer cells s...

Descripción completa

Detalles Bibliográficos
Autores principales: Mascaraque, Marta, Delgado-Wicke, Pablo, Nuevo-Tapioles, Cristina, Gracia-Cazaña, Tamara, Abarca-Lachen, Edgar, González, Salvador, Cuezva, José M., Gilaberte, Yolanda, Juarranz, Ángeles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139992/
https://www.ncbi.nlm.nih.gov/pubmed/32183017
http://dx.doi.org/10.3390/cancers12030668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139992/
https://www.ncbi.nlm.nih.gov/pubmed/32183017
http://dx.doi.org/10.3390/cancers12030668

Ejemplares similares